✦ LIBER ✦

Early treatment with ACE inhibition may benefit HIV-associated nephropathy patients

Book ID: 117814430
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 26 KB
Volume: 31
Category: Article
ISSN: 0272-6386
DOI: 10.1053/ajkd.1998.v31.pm9531193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment extension may benefit female g

Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy

✍ Takeshi Nishimura; Kanji Yamaguchi; Hiroaki Hashimoto; Toshihisa Niimi; Chihiro 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

The Early Glycoprotein IIb/IIIa Inhibiti

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Association Between Angiographic Complic

Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) Angiographic Substudy

✍ Yuri B. Pride; Satishkumar Mohanavelu; Cafer Zorkun; Vijayalakshmi Kunadian; Rob 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 385 KB